Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm

Objective: Clazosentan (CLA) reduces cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). However, adverse events including pulmonary edema were reported. We examined whether the strict management of fluid balance reduces the adverse events and improves patient outcomes. Methods: Pati...

Full description

Bibliographic Details
Main Authors: Takaaki Itazu, Taichi Ikedo, Takeyoshi Tsutsui, Akihiro Niwa, Yuji Kushi, Saya Ozaki, Naoto Yamada, Koji Shimonaga, Eika Hamano, Kiyofumi Yamada, Hirotoshi Imamura, Hisae Mori, Koji Iihara, Hiroharu Kataoka
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-04-01
Series:Brain Hemorrhages
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589238X2300061X